According to an FDA enforcement report, the Indian drugmaker is voluntarily recalling nearly 65,000 bottles of atorvastatin calcium in the U.S. after a pharmacist reported finding a 20-milligram tablet in a sealed bottle marked for 10-milligram pills.
Pfizer, which had to recall an injectable drug last month, is now recalling three lots of an antidepressant after a pharmacist discovered a capsule of one of Pfizer's heart pills in an Effexor XR bottle, a potentially deadly combo.
The industry has been talking about, and slowly working toward, track-and-trace for many years. Now Pharma faces real deadlines that require action.
Consumers who purchase over-the-counter products like Tylenol online sometimes receive items that are expired, defective, or even counterfeit. Now Johnson & Johnson and Amazon are in a fight over how much the online giant should be doing to keep that from happening.
Nosco expects to make the hires as production ramps up at the new facility, which has already finished its first business order.
German drugmaker Fresenius received a scathing warning letter in July for a drug plant in India. Now, a blood-products plant in Puerto Rico has been sent a warning for a labeling issue which the agency said should have been resolved months, even years ago.
A new report on the future growth in pharma packaging says a move toward use of more contract operations like Frazier's PCI will be a big driver for those companies that make the plastic bottles, parental containers, blister packs, labels and other products that go into packaging up the drugs needed worldwide.
Novartis has repeatedly had to deal with issues at its over-the-counter operation in Lincoln, NE, and once again has been bitten by problems there. This time, the company is recalling more than 4.4 million bottles of Maalox from the U.S. and Canada because of problems with packaging.
GlaxoSmithKline is joining Sanofi in adding 2-D barcodes to the packaging for most of its vaccines sold in the U.S., allowing doctors' offices to scan crucial information into electronic medical records and potentially saving them significant time.
Some companies are unclear on whether the new notice allows them an additional 45-day window for updating their pricing.